The present invention relates to the use of compounds that enhance H3-histamine receptor activity, or activation (e.g. H3-histamine receptor agonists) for the treatment of dyskinesia. The compounds are particularly useful for treating dyskinesia associated with parkinsonian therapy.
申请公布号
WO0130346(A1)
申请公布日期
2001.05.03
申请号
WO2000GB04046
申请日期
2000.10.20
申请人
THE VICTORIA UNIVERSITY OF MANCHESTER;BROTCHIE, JONATHAN;HILL, MICHAEL;CROSSMAN, ALAN